Where does Thomas de Vlaam work?

Thomas de Vlaam is Partner at Pillar VC and Board director at Amplifyer Bio.

What does Thomas de Vlaam invest in?

Thomas de Vlaam invests in Biotech.

What companies has Thomas de Vlaam invested in?

Investments tracked here include Amplifyer Bio, Arvada Therapeutics, Thymmune.

Where did Thomas de Vlaam go to school?

Thomas de Vlaam studied at University of Groningen (Bachelor’s Degree, Medicine).

Thomas de Vlaam

Investor

Partner at Pillar VC · Board director at Amplifyer Bio

Boston, Massachusetts, United States

Find your path to Thomas

181 people in our graph share verified history with Thomas — schools, employers, funds. One of them is your warm intro.

Noubar AfeyanunlockedThomas: together at Flagship Pioneering (2021–2022)

×7Thomas: together at Flagship Pioneering

×2Thomas: together at Pillar VC

×2Thomas: together at Pillar

About

Thomas de Vlaam has built his career in biotech. Before Pillar VC, he was part of the founding team of Quotient Therapeutics at Flagship Pioneering, and earlier founded and led Amylon Therapeutics, an RNA therapeutics startup for rare neurodegenerative disease that he spun out of ProQR Therapeutics, where he headed CNS innovation. He holds a B.Sc. in International Medicine and Global Health and has contributed to multiple patents and publications.

Contact· self-published, not guessed

t•••@pillar.vcreveal

Invests in

Biotech

Board director at Amplifyer Bio

Intro paths

→

In turn, Thomas can intro founders to Amplifyer Bio's investors below.

Amplifyer Bio's investors · 1

Pillar VCBoston · $50K – $4M checks · since 2024

Experience

Pillar VCPartnercurrent2024 — present
Pillar VCPrincipal2022 — 2024
Flagship PioneeringCo-Founder FL86 (Quotient Therapeutics)2021 — 2022
Flagship PioneeringAssociate2021 — 2022Cambridge, Massachusetts, United States
Amylon TherapeuticsFounder & CEO2017 — 2022Leiden, the Netherlands
ProQR Therapeutics NVInnovation lead CNS2015 — 2017Leiden
ProQR Therapeutics NVResearch Intern2014 — 2015Leiden
University Medical Center GroningenResearch Intern2014
Summer School of Transplantation Medicine (SSTx')Student committee2012 — 2014

Investments

Investor

Amplifyer BioArvada TherapeuticsThymmune

Per the firm's website.

Colleagues at Pillar VC

Alec Nielsen

Founder & CEO, Asimov & Venture Partner at Pillar VC

Alex Reinhart

Associate at Pillar VC

Alex Ting

Director of Events & Operations at Pillar VC

Andras Forgacs

Co-Founder & Board Director, Modern Meadow, Fork & Goode, Organovo & Founding Pillar at Pillar VC

Andrea Coravos

Co-founder/CEO, HumanFirst & Venture Partner at Pillar VC

Andy Beck

CEO, PathAI & Founding Pillar at Pillar VC

Ash Ashutosh

CEO, Actifio & Founding Pillar at Pillar VC

Ash Ashutosh

Executive Advisory Board at NYU Innovation Venture Fund

Frequently asked questions

Who is Thomas de Vlaam?: Thomas de Vlaam has built his career in biotech. Before Pillar VC, he was part of the founding team of Quotient Therapeutics at Flagship Pioneering, and earlier founded and led Amylon Therapeutics, an RNA therapeutics startup for rare neurodegenerative disease that he spun out of ProQR Therapeutics, where he headed CNS innovation. He holds a B.Sc. in International Medicine and Global Health and has contributed to multiple patents and publications.
Where does Thomas de Vlaam work?: Thomas de Vlaam is Partner at Pillar VC and Board director at Amplifyer Bio.
What does Thomas de Vlaam invest in?: Thomas de Vlaam invests in Biotech.
What companies has Thomas de Vlaam invested in?: Investments tracked here include Amplifyer Bio, Arvada Therapeutics, Thymmune.
Where did Thomas de Vlaam go to school?: Thomas de Vlaam studied at University of Groningen (Bachelor’s Degree, Medicine).